Morgan Stanley Downgrades QLT Inc (QLTI) to Underweight

September 8, 2008 7:36 AM EDT

Morgan Stanley downgrades QLT Inc (Nasdaq: QLTI) from Equalweight to Underweight.

QLT Inc. is a global biopharmaceutical company with two commercial products, Visudyne and Eligard, which were derived from its two technology platforms, photodynamic therapy and Atrigel.


Related Categories

Downgrades

Stocks Mentioned

QLTI 2.00

+0.10 +5.26%
Volume: 649,840
Track QLTI


Related Entities


Add Your Comment